Big Pharma Split Corp.
PRM.TO · TSX
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | CA$12,863 | CA$15,057 | CA$17,530 | CA$32,617 |
| - Cash | CA$2,254 | CA$1,031 | CA$1,593 | CA$204 |
| + Debt | CA$12,252 | CA$11,573 | CA$10,718 | CA$10,297 |
| Enterprise Value | CA$22,861 | CA$25,600 | CA$26,656 | CA$42,710 |
| Revenue | -CA$896 | CA$736 | CA$1,113 | CA$719 |
| % Growth | -221.8% | -33.9% | 54.8% | – |
| Gross Profit | -CA$896 | CA$582 | CA$951 | CA$719 |
| % Margin | 100% | 79.1% | 85.4% | 100% |
| EBITDA | CA$0 | -CA$1,485 | CA$1,506 | -CA$448 |
| % Margin | -0% | -201.8% | 135.3% | -62.2% |
| Net Income | -CA$487 | -CA$1,778 | CA$1,240 | -CA$78 |
| % Margin | 54.4% | -241.7% | 111.3% | -10.9% |
| EPS Diluted | -0.41 | -1.54 | 0.99 | -0.066 |
| % Growth | 73.4% | -255.6% | 1,604.6% | – |
| Operating Cash Flow | CA$870 | -CA$873 | -CA$422 | -CA$790 |
| Capital Expenditures | -CA$0 | CA$0 | CA$0 | CA$0 |
| Free Cash Flow | CA$870 | -CA$873 | -CA$422 | -CA$790 |